Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-13-011085)

Filing Details

Accession Number:: 0001140361-13-011085
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-03-06 18:23:19
Reporting Period:: 2013-03-04

Filing Date:: 2013-03-06
Accepted Time:: 2013-03-06 18:23:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1557533	Robert Jeffrey Ajer	C/O Biomarin Pharmaceutical Inc., 105 Digital Drive Novato CA 94949	Svp, Chief Commercial Of	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-03-04	4,000	$21.51	14,570	No	4	M	Direct
Common Stock	Disposition	2013-03-04	4,000	$60.00	10,570	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy) Common Stock	Disposition	2013-03-04	4,000	$0.00	4,000	$21.51

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,500	2010-11-12	2020-05-11	No	4	M	Direct

Footnotes

Transaction made pursuant to a Rule 10b5-1 plan executed on December 11, 2012.
Original option grant vests 6/48th on November 12, 2010 and 1/48th on the 12th of each month thereafter.
Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.